TY - JOUR
T1 - Choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen
AU - Giovacchini, Giampiero
AU - Picchio, Maria
AU - Garcia-Parra, Rita
AU - Mapelli, Paola
AU - Briganti, Alberto
AU - Montorsi, Francesco
AU - Gianolli, Luigi
AU - Messa, Cristina
PY - 2013/1
Y1 - 2013/1
N2 - Purpose: The effectiveness of salvage therapy in prostate cancer is greater for low prostate specific antigen values. Therefore, early detection of tumor recurrence is warranted. [11C]choline positron emission tomography/computerized tomography has the potential of early restaging of prostate cancer with low prostate specific antigen, but the selection of patients at high risk for positive [11C]choline positron emission tomography/computerized tomography is desirable to optimize salvage therapy. Materials and Methods: This retrospective study included 75 patients with prostate cancer with an increasing prostate specific antigen less than 1.5 ng/ml after radical prostatectomy who never received antiandrogen deprivation therapy or salvage radiotherapy who underwent [11C]choline positron emission tomography/computerized tomography for the restaging of disease. Binary logistic regression was used to assess predictive factors of positive [ 11C]choline positron emission tomography/computerized tomography. Included variables were trigger prostate specific antigen, prostate specific antigen doubling time, age, pathological stage and Gleason score. Results: Median prostate specific antigen was 0.61 ng/ml. [11C]choline positron emission tomography/computerized tomography was positive in 16 of 75 patients (21%). On univariate analysis prostate specific antigen doubling time less than 6 months was the only factor significantly associated with an increased risk of positive [11C]choline positron emission tomography/computerized tomography (OR 7.77, 95% CI 2.34-25.80, p = 0.001). In patients with prostate specific antigen doubling time less than 6 months, the positive detection rate of [11C]choline positron emission tomography/computerized tomography increased to 50%. Conclusions: In patients with prostate cancer with biochemical failure after radical prostatectomy and prostate specific antigen less than 1.5 ng/ml, prostate specific antigen doubling time less than 6 months predicts positive [11C]choline positron emission tomography/computerized tomography. In these patients [ 11C]choline positron emission tomography/computerized tomography may reduce by 50% the number in whom salvage therapy is initiated empirically without knowing the disease location.
AB - Purpose: The effectiveness of salvage therapy in prostate cancer is greater for low prostate specific antigen values. Therefore, early detection of tumor recurrence is warranted. [11C]choline positron emission tomography/computerized tomography has the potential of early restaging of prostate cancer with low prostate specific antigen, but the selection of patients at high risk for positive [11C]choline positron emission tomography/computerized tomography is desirable to optimize salvage therapy. Materials and Methods: This retrospective study included 75 patients with prostate cancer with an increasing prostate specific antigen less than 1.5 ng/ml after radical prostatectomy who never received antiandrogen deprivation therapy or salvage radiotherapy who underwent [11C]choline positron emission tomography/computerized tomography for the restaging of disease. Binary logistic regression was used to assess predictive factors of positive [ 11C]choline positron emission tomography/computerized tomography. Included variables were trigger prostate specific antigen, prostate specific antigen doubling time, age, pathological stage and Gleason score. Results: Median prostate specific antigen was 0.61 ng/ml. [11C]choline positron emission tomography/computerized tomography was positive in 16 of 75 patients (21%). On univariate analysis prostate specific antigen doubling time less than 6 months was the only factor significantly associated with an increased risk of positive [11C]choline positron emission tomography/computerized tomography (OR 7.77, 95% CI 2.34-25.80, p = 0.001). In patients with prostate specific antigen doubling time less than 6 months, the positive detection rate of [11C]choline positron emission tomography/computerized tomography increased to 50%. Conclusions: In patients with prostate cancer with biochemical failure after radical prostatectomy and prostate specific antigen less than 1.5 ng/ml, prostate specific antigen doubling time less than 6 months predicts positive [11C]choline positron emission tomography/computerized tomography. In these patients [ 11C]choline positron emission tomography/computerized tomography may reduce by 50% the number in whom salvage therapy is initiated empirically without knowing the disease location.
KW - positron-emission tomography and computed tomography
KW - prostate-specific antigen
KW - prostatic neoplasms
UR - http://www.scopus.com/inward/record.url?scp=84870879580&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870879580&partnerID=8YFLogxK
U2 - 10.1016/j.juro.2012.09.001
DO - 10.1016/j.juro.2012.09.001
M3 - Article
C2 - 23164385
AN - SCOPUS:84870879580
VL - 189
SP - 105
EP - 110
JO - Journal of Urology
JF - Journal of Urology
SN - 0022-5347
IS - 1
ER -